Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB
Schelker RC, Andrulis M, Mueller G, Ushmorov A, Hart C, Herr W, Vogelhuber M, Iberl S, Grassinger J (2019)
Publication Type: Journal article
Publication year: 2019
Journal
Book Volume: 76
Pages Range: 78-81
DOI: 10.1016/j.bcmd.2019.02.005
Involved external institutions
Universitätsklinikum Regensburg
Germany (DE)
Universität Ulm
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Germany (DE)
Universität Ulm
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
How to cite
APA:
Schelker, R.C., Andrulis, M., Mueller, G., Ushmorov, A., Hart, C., Herr, W.,... Grassinger, J. (2019). Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB. Blood Cells Molecules and Diseases, 76, 78-81. https://doi.org/10.1016/j.bcmd.2019.02.005
MLA:
Schelker, Roland Christian, et al. "Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB." Blood Cells Molecules and Diseases 76 (2019): 78-81.
BibTeX: Download